Steatohepatitis/Metabolic Liver Disease

You have free access to this content

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease†‡

  1. Vincent Wai-Sun Wong1,2,
  2. Julien Vergniol3,
  3. Grace Lai-Hung Wong1,2,
  4. Juliette Foucher3,
  5. Henry Lik-Yuen Chan1,2,
  6. Brigitte Le Bail4,5,
  7. Paul Cheung-Lung Choi6,
  8. Mathurin Kowo3,
  9. Anthony Wing-Hung Chan6,
  10. Wassil Merrouche3,
  11. Joseph Jao-Yiu Sung1,2,
  12. Victor de Lédinghen3,4,§,*

Article first published online: 9 SEP 2009

DOI: 10.1002/hep.23312

Issue

Hepatology

Hepatology

Volume 51, Issue 2, pages 454–462, February 2010

Additional Information

How to Cite

Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chan, H. L.-Y., Le Bail, B., Choi, P. C.-L., Kowo, M., Chan, A. W.-H., Merrouche, W., Sung, J. J.-Y. and de Lédinghen, V. (2010), Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology, 51: 454–462. doi: 10.1002/hep.23312

Author Information

  1. 1

    Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China

  2. 2

    Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China

  3. 3

    Centre d'Investigation de la Fibrose Hépatique, Centre Hospitalier Universitaire (CHU) de Bordeaux, Hôpital Haut-Lévêque, France

  4. 4

    Institut National de la Santé et de la Recherche Médicale U889, Université Victor Segalen, Bordeaux, France

  5. 5

    Service d'Anatomie Pathologique, CHU de Bordeaux, Hôpital Pellegrin, France

  6. 6

    Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, China

  1. §

    fax: (33)-557-656-445.

*Service d'Hépato-Gastroentérologie, Hôpital Haut-Lévêque, 33604 Pessac Cedex, France

  1. †

    See Editorial on page 370.

  2. ‡

    Potential conflict of interest: Dr. Chan advises and is on the speakers' bureau of Novartis and Bristol-Myers Squibb. He also advises Pharmasset and Schering-Plough. Dr. Sung advises and is on the speakers' bureau of AstraZeneca, GlaxoSmithKline, and Roche.

Publication History

  1. Issue published online: 25 JAN 2010
  2. Article first published online: 9 SEP 2009
  3. Accepted manuscript online: 9 SEP 2009 12:00AM EST
  4. Manuscript Accepted: 2 SEP 2009
  5. Manuscript Received: 18 JUL 2009

Funded by

  • Research fund of the Department of Medicine and Therapeutics, The Chinese University of Hong Kong

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (263K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stephen P. Casey, William W. Kemp, Catriona A. McLean, Duncan J. Topliss, Leon A. Adams, Stuart K. Roberts, A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease, Scandinavian Journal of Gastroenterology, 2012, 1

    CrossRef

  2. 2
    Mireen Friedrich-Rust, Daniela Romen, Johannes Vermehren, Susanne Kriener, Dilek Sadet, Eva Herrmann, Stefan Zeuzem, Joerg Bojunga, Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD, European Journal of Radiology, 2012, 81, 3, e325

    CrossRef

  3. 3
    Vincent Leroy, Seung Up Kim, Can transient elastography be used for the management of chronic hepatitis B patients?, Liver International, 2012, 32, 4
    Direct Link:
  4. 4
    Johannes Vermehren, Andreas Polta, Olga Zimmermann, Eva Herrmann, Thierry Poynard, Wolf-Peter Hofmann, Jörg Bojunga, Christoph Sarrazin, Stefan Zeuzem, Mireen Friedrich-Rust, Comparison of acoustic radiation force impulse imaging with transient elastography for the detection of complications in patients with cirrhosis, Liver International, 2012, 32, 5
    Direct Link:
  5. 5
    Mikako Obika, Hirofumi Noguchi, Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease, Experimental Diabetes Research, 2012, 2012, 1

    CrossRef

  6. 6
    Victor de Lédinghen, Vincent Wai-Sun Wong, Julien Vergniol, Grace Lai-Hung Wong, Juliette Foucher, Shirley Ho-Ting Chu, Brigitte Le Bail, Paul Cheung-Lung Choi, Faiza Chermak, Karen Kar-Lum Yiu, Wassil Merrouche, Henry Lik-Yuen Chan, Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan®, Journal of Hepatology, 2012, 56, 4, 833

    CrossRef

  7. 7
    Robert P. Myers, Gilles Pomier-Layrargues, Richard Kirsch, Aaron Pollett, Melanie Beaton, Mark Levstik, Andres Duarte-Rojo, David Wong, Pam Crotty, Magdy Elkashab, Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe, Journal of Hepatology, 2012, 56, 3, 564

    CrossRef

  8. 8
    Tae Hoon Lee, W. Ray Kim, John J. Poterucha, Evaluation of Elevated Liver Enzymes, Clinics in Liver Disease, 2012, 16, 2, 183

    CrossRef

  9. 9
    Maud Lemoine, Lawrence Serfaty, Jacqueline Capeau, From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients, Current Opinion in Infectious Diseases, 2012, 25, 1, 10

    CrossRef

  10. 10
    Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Winnie Chiu-Wing Chu, Angel Mei-Ling Chim, Arlinking Ong, David Ka-Wai Yeung, Karen Kar-Lum Yiu, Shirley Ho-Ting Chu, Hoi-Yun Chan, Jean Woo, Francis Ka-Leung Chan, Henry Lik-Yuen Chan, Hepatitis B virus infection and fatty liver in the general population, Journal of Hepatology, 2012, 56, 3, 533

    CrossRef

  11. 11
    Elliot B. Tapper, Eric B. Cohen, Keyur Patel, Bruce Bacon, Stuart Gordon, Eric Lawitz, David Nelson, Imad A. Nasser, Tracy Challies, Nezam Afdhal, Levels of Alanine Aminotransferase Confound Use of Transient Elastography to Diagnose Fibrosis in Patients With Chronic Hepatitis C Virus Infection, Clinical Gastroenterology and Hepatology, 2012,

    CrossRef

  12. 12
    Jérôme Boursier, Marie-Christine Rousselet, Christophe Aubé, Paul Calès, Liver fibrosis in patients with non-alcoholic fatty liver disease: diagnostic options in clinical practice, Expert Opinion on Medical Diagnostics, 2012, 1

    CrossRef

  13. 13
    Kristoffer Lindvig, Belinda K. Mössner, Court Pedersen, Søren T. Lillevang, Peer.B. Christensen, Liver stiffness and 30-day mortality in a cohort of patients admitted to hospital, European Journal of Clinical Investigation, 2012, 42, 2
    Direct Link:
  14. 14
    Ki Tae Yoon, Sun Min Lim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Chae Yoon Chon, Mong Cho, Jun Woo Lee, Seung Up Kim, Liver Stiffness Measurement Using Acoustic Radiation Force Impulse (ARFI) Elastography and Effect of Necroinflammation, Digestive Diseases and Sciences, 2012, 57, 6, 1682

    CrossRef

  15. 15
    Geoffrey C. Farrell, Derrick van Rooyen, Lay Gan, Shivrakumar Chitturi, NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications, Gut and Liver, 2012, 6, 2, 149

    CrossRef

  16. 16
    Jiayun Shen, Henry Lik-Yuen Chan, Grace Lai-Hung Wong, Paul Cheung-Lung Choi, Anthony Wing-Hung Chan, Hoi-Yun Chan, Angel Mei-Ling Chim, David Ka-Wai Yeung, Francis Ka-Leung Chan, Jean Woo, Jun Yu, Winnie Chiu-Wing Chu, Vincent Wai-Sun Wong, Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers, Journal of Hepatology, 2012, 56, 6, 1363

    CrossRef

  17. 17
    Z. Yu, V. W.-S. Wong, G. L.-H. Wong, Non-invasive algorithms for liver fibrosis, Alimentary Pharmacology & Therapeutics, 2012, 35, 2
    Direct Link:
  18. 18
    Angelo H. Paredes, Dawn M. Torres, Stephen A. Harrison, Nonalcoholic Fatty Liver Disease, Clinics in Liver Disease, 2012, 16, 2, 397

    CrossRef

  19. 19
    Anna Alisi, Ariel E. Feldstein, Alberto Villani, Massimiliano Raponi, Valerio Nobili, Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach, Nature Reviews Gastroenterology & Hepatology, 2012, 9, 3, 152

    CrossRef

  20. 20
    Hitoshi Ikeda, Kazuaki Tejima, Ryota Masuzaki, Yutaka Yatomi, Kazuhiko Koike, Reply to the letter by H. Mawatari et al. regarding “Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly”, Journal of Gastroenterology, 2012, 47, 5, 608

    CrossRef

  21. 21
    Victor de Lédinghen, Julien Vergniol, Concepcion Gonzalez, Juliette Foucher, Elisa Maury, Louise Chemineau, Sandrine Villars, Henri Gin, Vincent Rigalleau, Screening for liver fibrosis by using FibroScan® and FibroTest in patients with diabetes, Digestive and Liver Disease, 2012, 44, 5, 413

    CrossRef

  22. 22
    Maud Lemoine, Lawrence Serfaty, Stéatopathies métaboliques, La Presse Médicale, 2012, 41, 2, 169

    CrossRef

  23. 23
    M. Sasso, V. Miette, L. Sandrin, M. Beaugrand, The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®, Clinics and Research in Hepatology and Gastroenterology, 2012, 36, 1, 13

    CrossRef

  24. 24
    Cristina Rigamonti, Mirella Fraquelli, Anan Judina Bastiampillai, Lucio Caccamo, Paolo Reggiani, Giorgio Rossi, Massimo Colombo, Maria Francesca Donato, Transient elastography identifies liver recipients with nonviral graft disease after transplantation: A guide for liver biopsy, Liver Transplantation, 2012, 18, 5
    Direct Link:
  25. 25
    Roslyn Vongsuvanh, Jacob George, Duncan McLeod, David van der Poorten, Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease, Journal of Hepatology, 2012,

    CrossRef

  26. 26
    Elizabeth M. Brunt, Brent A. Neuschwander-Tetri, Alastair D. Burt, MacSween's Pathology of the Liver, 2012,

    CrossRef

  27. 27
    Ali A. Mencin, Joel E. Lavine, Advances in Pediatric Nonalcoholic Fatty Liver Disease, Pediatric Clinics of North America, 2011, 58, 6, 1375

    CrossRef

  28. 28
    L. Castera, Comment diagnostiquer de façon non invasive la fibrose au cours de la stéatopathie métabolique ?, Médecine des Maladies Métaboliques, 2011, 5, 1, 60

    CrossRef

  29. 29
    J. K. Dowman, M. J. Armstrong, J. W. Tomlinson, P. N. Newsome, Current therapeutic strategies in non-alcoholic fatty liver disease, Diabetes, Obesity and Metabolism, 2011, 13, 8
    Direct Link:
  30. 30
    Samer Gawrieh, Darly M. Knoedler, Kia Saeian, James R. Wallace, Richard A. Komorowski, Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology, Annals of Diagnostic Pathology, 2011, 15, 1, 19

    CrossRef

  31. 31
    José A. Carrión, Miquel Navasa, Maria Buti, Xavier Torras, Xavier Xiol, Mercedes Vergara, Ramón Planas, Ricard Solà, Xavier Forns, Elastografía hepática. Documento de posicionamiento de la Societat Catalana de Digestologia, Gastroenterología y Hepatología, 2011, 34, 7, 504

    CrossRef

  32. 32
    Alexander Koch, Andreas Horn, Hanna Dückers, Eray Yagmur, Edouard Sanson, Jan Bruensing, Lukas Buendgens, Sebastian Voigt, Christian Trautwein, Frank Tacke, Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU, Critical Care, 2011, 15, 6, R266

    CrossRef

  33. 33
    Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, Is transient elastography inaccurate in chronic hepatitis B and non-alcoholic fatty liver disease?, Journal of Hepatology, 2011, 55, 2, 497

    CrossRef

  34. 34
    Eiichi Ogawa, Norihiro Furusyo, Masayuki Murata, Hachiro Ohnishi, Kazuhiro Toyoda, Hiroaki Taniai, Takeshi Ihara, Hiroaki Ikezaki, Takeo Hayashi, Mosaburo Kainuma, Jun Hayashi, Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog, Hepatology Research, 2011, 41, 12
    Direct Link:
  35. 35
    Lay Gan, Shivakumar Chitturi, Geoffrey C. Farrell, Mechanisms and Implications of Age-Related Changes in the Liver: Nonalcoholic Fatty Liver Disease in the Elderly, Current Gerontology and Geriatrics Research, 2011, 2011, 1

    CrossRef

  36. 36
    Giovanni Musso, Roberto Gambino, Maurizio Cassader, Gianfranco Pagano, Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity, Annals of Medicine, 2011, 43, 8, 617

    CrossRef

  37. 37
    Jeong Wan Seo, Nonalcoholic Fatty Liver Disease in Children, Korean Journal of Pediatric Gastroenterology and Nutrition, 2011, 14, 3, 209

    CrossRef

  38. 38
    Éric Bavu, Jean-Luc Gennisson, Mathieu Couade, Jeremy Bercoff, Vincent Mallet, Mathias Fink, Anne Badel, AnaÏs Vallet-Pichard, Bertrand Nalpas, Mickaël Tanter, Stanislas Pol, Noninvasive In Vivo Liver Fibrosis Evaluation Using Supersonic Shear Imaging: A Clinical Study on 113 Hepatitis C Virus Patients, Ultrasound in Medicine & Biology, 2011, 37, 9, 1361

    CrossRef

  39. 39
    Silvia Gaia, Silvia Carenzi, Angela L. Barilli, Elisabetta Bugianesi, Antonina Smedile, Franco Brunello, Alfredo Marzano, Mario Rizzetto, Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitis, Journal of Hepatology, 2011, 54, 1, 64

    CrossRef

  40. 40
    Silvia Gaia, Reply to: “Is transient elastography inaccurate in chronic hepatitis B and non-alcoholic fatty liver disease?”, Journal of Hepatology, 2011, 55, 2, 498

    CrossRef

  41. 41
    Suzanne E. Mahady, Angela C. Webster, Sarah Walker, Arun Sanyal, Jacob George, The role of thiazolidinediones in non-alcoholic steatohepatitis – A systematic review and meta analysis, Journal of Hepatology, 2011, 55, 6, 1383

    CrossRef

  42. 42
    James Fung, Ching-Lung Lai, Wai-Kay Seto, Man-Fung Yuen, The use of transient elastography in the management of chronic hepatitis B, Hepatology International, 2011, 5, 4, 868

    CrossRef

  43. 43
    Marcin Krawczyk, Frank Grünhage, Vincent Zimmer, Frank Lammert, Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: Non-invasive elastography-based study in chronic liver disease, Journal of Hepatology, 2011, 55, 2, 299

    CrossRef

  44. 44
    Julien Calderaro, Elie Serge Zafrani, Stéatopathie hépatique non alcoolique, Annales de Pathologie, 2010, 30, 6, 413

    CrossRef

  45. 45
    Anna Alisi, Massimo Pinzani, Valerio Nobili, Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease, Hepatology, 2009, 50, 6
    Direct Link:
  46. 46
    Vincent Wai-Sun Wong, Julien Vergniol, Henry Lik-Yuen Chan, Victor de Lédinghen, Reply:, Hepatology, 2009, 50, 6
    Direct Link:
  47. 47
    Stephen H. Caldwell, Curtis K. Argo, Abdullah M. S. Al-Osaimi, Nonalcoholic Fatty Liver Disease,
    Direct Link:
  48. 48
    Joanna K. Dowman, Phil N. Newsome, The Chronic Liver Disease Patient,
    Direct Link:
View Full Article (HTML) Get PDF (263K)